Durect Newsroom

Are Medical Stocks Lagging DURECT (DRRX) This Year?

Yahoo FinanceJun 19 21:40

H.C. Wainwright Maintains Durect(DRRX.US) With Hold Rating

H.C. Wainwright analyst Ed Arce maintains $Durect(DRRX.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 39.3% and a total average return of 8.6% over the past year

Futu NewsMay 23 17:34

Northland Securities Maintains Durect(DRRX.US) With Buy Rating, Maintains Target Price $8.5

Northland Securities analyst Carl Byrnes maintains $Durect(DRRX.US)$ with a buy rating, and maintains the target price at $8.5.According to TipRanks data, the analyst has a success rate of 37.0% and a

Futu NewsMay 23 13:31

Analysts Are Bullish on Top Healthcare Stocks: Guardant Health (GH), Durect (DRRX)

TipRanksMay 22 21:00

12 Health Care Stocks Moving In Tuesday's After-Market Session

GainersRezolute (NASDAQ:RZLT) stock increased by 52.7% to $4.58 during Tuesday's after-market session. The company's market cap stands at $183.8 million. The company's, Q3 earnings came out 4 days ago

BenzingaMay 22 04:31

Hearing Oppenheimer Reiterates Outperform And $5 PT On DURECT

Hearing Oppenheimer Reiterates Outperform And $5 PT On DURECT

BenzingaMay 22 02:52

Sector Update: Health Care Stocks Edge Higher Tuesday Afternoon

Health care stocks were edging up Tuesday afternoon, with the NYSE Health Care Index rising 0.2% and the Health Care Select Sector SPDR Fund (XLV) fractionally higher. The iShares Biotechnology ETF (I

MT NewswiresMay 22 01:55

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

GainersBiodexa Pharmaceuticals (NASDAQ:BDRX) shares increased by 67.7% to $2.13 during Tuesday's pre-market session. The market value of their outstanding shares is at $9.3 million. Durect (NASDAQ:DRR

BenzingaMay 21 20:06

DURECT Corporation Receives FDA Breakthrough Therapy Designation For Larsucosterol In Alcohol-Associated Hepatitis

DURECT Corporation Receives FDA Breakthrough Therapy Designation For Larsucosterol In Alcohol-Associated Hepatitis

BenzingaMay 21 20:03

The US government's latest move has triggered changes in the US marijuana sector. Biden personally filmed a short video to help

Biden stressed that the policy on reclassification of marijuana was launched at his request.

cls.cnMay 17 08:24

HC Wainwright & Co. Reiterates Neutral on Durect

HC Wainwright & Co. analyst Ed Arce reiterates Durect (NASDAQ:DRRX) with a Neutral.

BenzingaMay 15 22:53

Durect | 10-Q: Quarterly report

SEC announcementMay 15 04:45 · Announcements

DURECT Shares Are Trading Lower After the Company Reported a Year-over-year Decrease in Q1 Revenue Results.

DURECT Shares Are Trading Lower After the Company Reported a Year-over-year Decrease in Q1 Revenue Results.

BenzingaMay 15 01:59

Durect Far From Earnings Story But FDA Commentary Shows Path Forward, Oppenheimer Says

Durect (DRRX) is not yet an earnings story but recent feedback from the US Food and Drug Administration is encouraging over its support for the advancement of larsucosterol into a single late-stage tr

MT NewswiresMay 15 01:21

Cutera, Inotiv, Treace Medical Concepts Among Healthcare Movers

Seeking AlphaMay 14 22:00

Durect (DRRX) Gets a Buy From Oppenheimer

TipRanksMay 14 19:56

Durect (DRRX) Receives a Hold From H.C. Wainwright

TipRanksMay 14 18:32

Durect Corp (DRRX) Q1 2024 Earnings Call Transcript Highlights: Navigating Financial Challenges ...

Yahoo FinanceMay 14 15:03

Earnings Call Summary | Durect(DRRX.US) Q1 2024 Earnings Conference

The following is a summary of the DURECT Corporation (DRRX) Q1 2024 Earnings Call Transcript:Financial Performance:DURECT Corporation reported a decline in revenue from $2.1 million in 2023 to $1.8 mi

Futu NewsMay 14 12:16 · Conference Call

Durect (DRRX) Reports Q1 Loss, Misses Revenue Estimates

Yahoo FinanceMay 14 05:20